Inhibition of colistin resistance in gram-negative pathogens by natural compounds
cun id:
1936
SCOPERTA E DESIGN DI FARMACI
Identification of new Smo and Gli antagonists bearing the isoflavone scaffold for medulloblastoma treatment.
Polymer or surfactant-based nanoencapsulation of cannabidiol and its new analogues: preparation, characterization and evaluation of antibacterial activity
Novel saccharin-based and acesulfame-based selective inhibitors of the tumor-associated human carbonic anhydrases IX and XII. Synthesis, biological evaluation and SPR studies.
Oncogenic role of the aminopeptidase ERAP1 in Hedgehog-dependent cancer
Novel Smo and Gli1 inhibitors for targeting Hedgehog pathway: identification within modeling screening and their green synthesis, in vitro and in vivo tests through improved drug delivery strategies to enhance the therapeutic effects.
Targeting Notch3-driven cancers by means of novel Notch3 receptor intercepting molecules
Non-coding RNAs and epigenetic drivers in ovarian cancer development and drug resistance: cues to new biomarkers and efficient targeted therapies.
Sviluppo di nuovi multitarget directed ligands come potenziali agenti nella terapia del morbo di Alzheimer.
Amphibian skin-derived peptides as novel tools against drug-resistant respiratory microbial and viral strains in elderly and cystic fibrosis patients